Xeris Biopharma Holdings Inc
F:2B30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xeris Biopharma Holdings Inc
F:2B30
|
US |
|
Azienda Bresciana Petroli Nocivelli SpA
F:9UZ
|
IT |
|
J
|
JAFCO Group Co Ltd
SWB:JAF
|
JP |
|
Aritzia Inc
F:280
|
CA |
|
Sleep Country Canada Holdings Inc
F:1S2
|
CA |
|
C
|
Caspian Sunrise PLC
SWB:RO1
|
UK |
|
O
|
Oracle Corp
BMV:ORCL
|
US |
|
D
|
Direct Line Insurance Group PLC
F:D1LN
|
UK |
|
O
|
Oracle Corp
F:ORC
|
US |
|
Citius Pharmaceuticals Inc
F:47N
|
US |
|
S
|
Suncor Energy Inc
F:SM3
|
CA |
|
I Grandi Viaggi SpA
F:95H
|
IT |
|
M
|
Medical Properties Trust Inc
F:M3P
|
US |
|
C
|
Caspian Sunrise PLC
F:RO1
|
UK |
|
H
|
HALEON PLC
F:H6D
|
UK |
|
B
|
Ballard Power Systems Inc
XMUN:PO0
|
CA |
|
C
|
Caspian Sunrise PLC
OTC:ROXIF
|
UK |
|
U
|
Urban Outfitters Inc
F:UOF
|
US |
|
P
|
PostNL NV
XHAM:TNTC
|
NL |
|
A
|
Alps Alpine Co Ltd
OTC:APELY
|
JP |
Wall St Price Targets
2B30 Price Targets Summary
Xeris Biopharma Holdings Inc
According to Wall Street analysts, the average 1-year price target for 2B30 is 14.04 EUR with a low forecast of 9.98 EUR and a high forecast of 23.35 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2B30's stock price target?
Price Target
14.04
EUR
According to Wall Street analysts, the average 1-year price target for 2B30 is 14.04 EUR with a low forecast of 9.98 EUR and a high forecast of 23.35 EUR.
What is the Revenue forecast for Xeris Biopharma Holdings Inc?
Projected CAGR
10%
Over the last 8 years, the compound annual growth rate for Revenue has been 92%. The projected CAGR for the next 7 years is 10%.
What is the Operating Income forecast for Xeris Biopharma Holdings Inc?
Projected CAGR
62%
The compound annual growth rate for Operating Income over the next 5 years is 62%.
What is the Net Income forecast for Xeris Biopharma Holdings Inc?
Projected CAGR
462%
The compound annual growth rate for Net Income over the next 3 years is 462%.
